-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) PT Lowered to $64 at Jefferies
-
-
-
-
-
-
-
Gilead Sciences (GILD) Trades at High, Up 4.3%
-
-
-
-
-
-
-
Gilead Sciences to Present at Upcoming Investor Conference
-
-
-
-
-
-
-
Gilead Sciences (GILD) HIV KOL Call Bodes Well for Long Acting HIV - Jefferies
-
-
-
-
-
-
-
Gilead Sciences to Present at Upcoming Investor Conferences
-
-
-
-
-
-
-
Gilead's shares rise after $21 billion deal for Immunomedics
-
-
-
-
-
-
-
AstraZeneca contacted Gilead over potential megamerger: Bloomberg News
-
74,496 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


